FDA Recalls Testosterone Pellets Due to Sterility Assurance Concerns
Moses Lake Professional Pharmacy is recalling 355 testosterone pellets because the FDA cannot assure they are sterile. Patients should stop using the product and consult a healthcare provider.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The source text explicitly identifies the recall as FDA Class II. According to the severity rubric, FDA Class II recalls with potential for hospitalization or significant injury are classified as Severe (Score 4). While no specific injuries are reported in the text, the agency's classification mandates a minimum score of 4.
Plain-English summary
The U.S. Food and Drug Administration (FDA) has issued a Class II recall for 355 units of Testosterone, Pellet, 125 mg, manufactured by JD & SN Inc., dba Moses Lake Professional Pharmacy. The recall was initiated due to a lack of assurance of sterility for all sterile human compounded drugs within their expiry dates.
The affected product is a prescription-only medication distributed nationwide. The recall covers specific lots identified by codes ranging from 01052015@21 to t06272014@20. The FDA classifies this as a Class II recall, indicating that use of the product could cause temporary or medically reversible health problems, or where the probability of serious adverse health consequences is remote.
Patients who have received this product should stop using it immediately and consult their healthcare provider for further instructions. The recalling firm is responsible for managing the recall and ensuring the product is removed from distribution.
The recalled product
- Product
- TESTOSTERONE, Pellet, 125 mg, Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA 98837, (509)764-2314
- Category
- Drug — Compounded Sterile Drug
- Affected units
- 355
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- 01052015@21
- 01162015@21
- 02122015@8
- 03252015@14
- 04022015@14
- 04102015@8
- 04172015@30
- 05192015@8
- 06162014@12
- 07102015@6
- 07222014@18
- 08072014@3
- 08192014@5
- 09022014@36
- 09102014@26
- 09192014@19
- 10032014@25
- 10092014@11
- 10282014@1
- 10312014@8
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 101 recalled by JD & SN Inc., dba Moses Lake Professional Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 101 products in this recall →Related recalls
Same manufacturer · JD & SN Inc., dba Moses Lake Professional Pharmacy
See all →- SevereFDA Recalls Estradiol Pellets Due to Lack of Sterility Assurance
FDA (Drugs) · 2015-11-04
- SevereFDA Recalls Sodium Tetradecyl Sulfate Syringes Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereMoses Lake Pharmacy Recalls Six Trimix Syringes Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereMoses Lake Pharmacy Recalls Compounded Chorionic Gonadotropin Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereFDA Recalls Compounded Progesterone Pellets Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
Same hazard · sterility failure
See all →- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22
Similar recalls
- SevereQualgen Recalls Testosterone Pellets Due to Sterility Assurance Concerns
FDA (Drugs) · 2018-11-14
- HighQualgen Recalls Testosterone Pellets Due to Sterility Concerns
FDA (Drugs) · 2018-11-14
- HighTestosterone Pellets Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-09-23
- SevereTestosterone Sterile Pellets Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2015-09-23
- SevereTestosterone Pellets Recalled for Potential Sterility Assurance Issues
FDA (Drugs) · 2015-09-23
- SevereTestosterone and B12 Pellet Recalled for Sterility Assurance Issues
FDA (Drugs) · 2015-09-23